Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H2, 2016 - New Market Research Report
GlobalData's clinical trial report, "Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H2, 2016" provides an overview of Refractory Acute Myeloid Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on Refractory Acute Myeloid Leukemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
View full press release